D-1344-2014 Class II Terminated
FDA drug recall D-1344-2014 was initiated by SigmaPharm Laboratories LLC on Apr 22, 2014 and is designated Class II. Reason for recall: Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously… The recall status is terminated (terminated Mar 16, 2015). Affected quantity: 43,007 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 28, 2014
- Initiation Date
- Apr 22, 2014
- Termination Date
- Mar 16, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,007 Bottles
Product description
Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.
Reason for recall
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1344-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026